Daptomycin Injection, Powder, Lyophilized, For Suspension
Product Images NDC 14335-120

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 14335-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hainan Poly Pharm., Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Image 01)

Chemical-structure (Image 01)
Chemical structure diagram of daptomycin showing its detailed molecular arrangement with labeled atoms including carbon, hydrogen, oxygen, and nitrogen.*
FDA Label Image

Vial (Image Vial)

Vial (Image Vial)
Label for daptomycin for Injection 500 mg per vial, lyophilized powder for intravenous infusion. It includes storage instructions stating the product must be refrigerated at 2° to 8°C and is for single-dose use with unused portions discarded. The label indicates it is manufactured by Hainan Poly Pharm., Co., Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.